Patents by Inventor Natalia VASYLIEVA

Natalia VASYLIEVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOBODIES AGAINST CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITORY FACTOR (Cif)
    Publication number: 20220169708
    Abstract: Provided are VHH or nanobodies that specifically bind to cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif), and uses thereof for diagnosis and treatment of Pseudomonas infection.
    Type: Application
    Filed: December 7, 2021
    Publication date: June 2, 2022
    Inventors: Bruce D. HAMMOCK, Natalia VASYLIEVA, Jiexian DONG, Christophe MORISSEAU, Dean R. MADDEN
  • Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)
    Patent number: 11225514
    Abstract: Provided are VHH or nanobodies that specifically bind to cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif), and uses thereof for diagnosis and treatment of Pseudomonas infection.
    Type: Grant
    Filed: May 29, 2018
    Date of Patent: January 18, 2022
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: Bruce D. Hammock, Natalia Vasylieva, Jiexian Dong, Christophe Morisseau, Dean R. Madden
  • NANOBODIES AGAINST CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) INHIBITORY FACTOR (Cif)
    Publication number: 20200231659
    Abstract: Provided are VHH or nanobodies that specifically bind to cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif), and uses thereof for diagnosis and treatment of Pseudomonas infection.
    Type: Application
    Filed: May 29, 2018
    Publication date: July 23, 2020
    Inventors: Bruce D. HAMMOCK, Natalia VASYLIEVA, Jiexian DONG, Christophe MORISSEAU, Dean R. MADDEN